Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

69.28
-1.0700-1.52%
Pre-market: 70.230.9500+1.37%05:42 EDT
Volume:7.48M
Turnover:509.69M
Market Cap:12.58B
PE:-48.32
High:69.75
Open:68.86
Low:66.71
Close:70.35
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.82
T/O Rate:6.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:28.27
PE(LYR):-49.13

Loading ...

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS
·
Jun 01

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Dow Jones
·
Jun 01

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)

TIPRANKS
·
Jun 01

Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development

MT Newswires Live
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Short Report: Tempus AI short interest at record high

TIPRANKS
·
Jun 01

Consumer Tech News (May 25-29): Dell, IBM, CrowdStrike, Meta Lead Big Tech AI Push

Benzinga Earnings
·
May 31

Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs

TIPRANKS
·
May 31

Tempus AI announces introduction of Tempus Preview

TIPRANKS
·
May 31

Tempus AI CEO and Chairman Eric Lefkofsky reports sale of 166,250 common shares worth $7.76 million

Reuters
·
May 30

AI Application Software Shares Extended Gains. Palantir Up 10%; Salesforce And Rubrik Up 8%; Snowflake, GitLab And HubSpot Up 6%

Tiger Newspress
·
May 29

Tempus AI expects 25% top-line growth over next 3 years

TIPRANKS
·
May 29

Tempus AI reiterates FY26 revenue view of $1.59B-$1.6B, consensus $1.59B

TIPRANKS
·
May 29

Tempus AI announces initial results from Multimodal Foundation Model efforts

TIPRANKS
·
May 29

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune

Reuters
·
May 29

Tempus AI posts investor day presentation on AI-driven diagnostics, precision-medicine data platform

Reuters
·
May 29

Sector Update: Healthcare

MT Newswires Live
·
May 29

BUZZ-Tempus AI rises after securing FDA approval for tumor test

Reuters
·
May 29

Tempus AI Shares up 7.3% Premarket After FDA Approves Its Xt Cdx Test for Genetic Profiling of Tumors

THOMSON REUTERS
·
May 29